Lonza
David Serp is a seasoned professional in the biotechnology and biopharmaceutical industries, currently serving as Senior Vice President and Head of the Biologics Manufacturing Network at Lonza. Previously, David held various leadership positions at GSK Vaccines, including Vice President and Head of Rosia & Siena Industrial Operations, as well as overseeing Belgium Secondary Operations and Logistics. At Novartis Pharma, David was General Manager and held significant roles in production and sourcing. David also contributed to Sandoz GmbH as head of clinical manufacturing and biopharmaceutical collaborations. David holds a Ph.D. in biotechnology from EPFL and completed a postdoctoral fellowship in metabolic engineering at the University of California, Berkeley.
This person is not in any teams
This person is not in any offices
Lonza
68 followers
Lonza Group AG (Lonza) is a Switzerland-based holding company and a supplier to the pharmaceutical, healthcare and life-science industries. The Company divides its activities into four divisions: Life Science Ingredients; Microbial Control; Custom Manufacturing, and Bioscience. The Life Science Ingredients division comprises a range of products for applications in nutrition, hygiene, preservation, water treatment, materials protection, and other industrial markets. The Microbial Control division focuses on five areas: hygiene, wood protection, water treatment, oil/gas applications, and industrial preservation and comprises products ranging from disinfectants to household cleaning products. The Custom Manufacturing division comprises products used in pharmaceuticals sector. The Bioscience division comprises bioscience products, including cell culture and molecular biology tools for research, tests for microbial detection, and media used in the production of therapeutics.